Comparison of baseline data, initial course, and management: losartan versus captopril following acute myocardial infarction (the OPTIMAAL trial) - 03/09/11
Doi : 10.1016/S0002-9149(00)01500-9
Kenneth Dickstein, MD, PhD ⁎ 
, John Kjekshus, MD, PhD
, John Kjekshus, MD, PhDOPTIMAAL Trial Steering Committee and Investigators∗
Cardiology Division, Central Hospital in Rogaland, Stavanger, Norway, Department of Cardiology, Rikshospitalet, Oslo, Norway
*Dr. Dickstein’s address: Cardiology Division, Central Hospital in Rogaland, Stavanger, 4011, Norway
| ☆ | This study was supported by grants from Merck, Sharp, and Dohme Research Laboratories, West Point, Pennsylvania. |
© 2001
Excerpta Medica Inc. Tous droits réservés.
Vol 87 - N° 6
P. 766-771 - mars 2001 Retour au numéro
Article précédent
- Tissue factor as a therapeutic target in coronary syndromes
- Shmuel Banai, S.David Gertz
- Effect of concomitant or very early statin administration on in-hospital mortality and reinfarction in patients with acute myocardial infarction
- Kevin A. Bybee, R.Scott Wright, Brent A. Williams, Joseph G. Murphy, David R. Holmes, Stephen L. Kopecky
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?